Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

NF-κB in biology and targeted therapy: new insights and translational implications
Qing Guo, Yizi Jin, Xinyu Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 328
Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management
Zarina Mohd Zawawi, Jeevanathan Kalyanasundram, Rozainanee Mohd Zain, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6142-6142
Open Access | Times Cited: 41
Immune Response to Respiratory Viral Infections
Antonella Gambadauro, Francesca Galletta, Alessandra Li Pomi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6178-6178
Open Access | Times Cited: 14
Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 88
Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
Swarnali Das, Suvrendu Sankar Kar, Sovan Samanta, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 289-315
Open Access | Times Cited: 64
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 47
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 42
Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis
Fan Jiang, Yinping Liu, Yong Xue, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109728-109728
Open Access | Times Cited: 26
SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways
Jian Deng, Yi Zheng, Shengnan Zheng, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 24
Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2
Tiago Nicoliche, Cynthia Silva Bartolomeo, Robertha Mariana Rodrigues Lemes, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart
Jana Grune, Geetika Bajpai, Pervin Tülin Ocak, et al.
Circulation (2024) Vol. 150, Iss. 1, pp. 49-61
Open Access | Times Cited: 10
Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease
Carlos A. Labarrere, Ghassan S. Kassab
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 33
Individual genetic variability mainly of Proinflammatory cytokines, cytokine receptors, and toll‐like receptors dictates pathophysiology of COVID‐19 disease
Mohammad Kazem Vakil, Yaser Mansoori, Ghaidaa Raheem Lateef Al‐Awsi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4088-4096
Open Access | Times Cited: 30
Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality
Dun‐Xian Tan, Rüssel J. Reiter
Life Sciences (2022) Vol. 294, pp. 120368-120368
Open Access | Times Cited: 29
Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019
Jiayu Dai, Yibo Wang, Hongrui Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
Activation of TLR4 by viral glycoproteins: A double-edged sword?
Emily A. Halajian, Emmanuelle V. LeBlanc, Katrina Gee, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
The relationship between chronic immune response and neurodegenerative damage in long COVID-19
José Pedro Elizalde-Díaz, Clara Leticia Miranda-Narváez, Juan Carlos Martínez‐Lazcano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
SARS‐CoV‐2 NSP8 suppresses type I and III IFN responses by modulating the RIG‐I/MDA5, TRIF, and STING signaling pathways
Jian Deng, Shengnan Zheng, Yang Xiao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 15
The roles of the kynurenine pathway in COVID-19 neuropathogenesis
Mona Dehhaghi, Mostafa Heydari, Hamed Kazemi Shariat Panahi, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 2043-2059
Open Access | Times Cited: 6
A mid‑pandemic night's dream: Melatonin, from harbinger of anti‑inflammation to mitochondrial savior in acute and long COVID‑19 (Review)
Ioannis Lempesis, Vasiliki Georgakopoulou, Rüssel J. Reiter, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 3
Open Access | Times Cited: 5
Design and Evaluation of Synthetic Delivery Formulations for Peptide-Based Cancer Vaccines
Kefan Song, Suzie H. Pun
BME Frontiers (2024) Vol. 5
Open Access | Times Cited: 5
RNA viruses, TLRs, and cytokines: the perfect storm?
Sophia K. Stegeman, Olena Kourko, Heather Amsden, et al.
Journal of Innate Immunity (2025) Vol. 17, Iss. 1, pp. 126-153
Open Access
TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes
Lucero A. Ramón‐Luing, Laura E. Martínez-Gómez, Carlos Martínez-Armenta, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1139-1139
Open Access
Age-related immune response disparities between adults and children with severe COVID-19: a case–control study in China
Hongliang Chen, Yuan Li, Liping Yuan, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top